Do Inhaled Anticholinergics Increase or Decrease the Risk of Major Cardiovascular Events?: A Synthesis of the Available Evidence

Author： Salpeter Shelley R.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.69, Iss.15, 2009-10, pp. : 2025-2033

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhaled anticholinergics: increased risk of major adverse CV events?

By  

Inpharma, Vol. 1, Iss. 1658, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Do Some Inhibitors of COX-2 Increase the Risk of Thromboembolic Events?: Linking Pharmacology with Pharmacoepidemiology

By Clark D.W.J.   Layton D.   Shakir S.A.W.  

Drug Safety, Vol. 27, Iss. 7, 2004-01 ,pp. : 427-456

Adis International

Access to resources Recommend Favorite

COX-2 inhibitors: increased risk of CV events?

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Inhaled anticholinergics increase risk of acute urinary retention

By  

Reactions Weekly, Vol. 1, Iss. 1359, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Do antipsychotics increase the risk of death in dementia?

By  

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite